MDSAP Auditing

We identify gaps
before the external auditor finds them.

Internal and second-party auditing under ISO 13485:2016, the MDSAP Audit Approach and ISO 19011:2026. Conducted by accredited lead auditors, with reporting in the format expected by Auditing Organisations.

See types of audit
  • 🇧🇷 ANVISA
  • 🇺🇸 FDA
  • 🇨🇦 Health Canada
  • 🇦🇺 TGA
  • 🇯🇵 PMDA
Why internal auditing?

It is a requirement of MDSAP P3. And your best protection.

Internal auditing is a central element of MDSAP, explicitly required in process P3 (Measurement, Analysis and Improvement). More than a formal requirement, it demonstrates the QMS's capacity for continuous self-assessment - and distinguishes companies that pass from those receiving findings during certification.

  • P3 / MDSAPan explicit programme requirement
  • ISO 19011official methodology applied
  • Grade 1-5categorised severity
Types of audit

What we conduct.

Three types of audit, selected according to the objective: certification preparation, certificate maintenance or critical supplier assessment.

MDSAP internal auditing

A complete QMS assessment across all 7 processes (P1-P7) of the MDSAP Audit Approach. For companies preparing for certification or fulfilling the mandatory annual cycle.

  • Full coverage of processes P1 to P7
  • Official tasks and linked items
  • Reporting in the AOs' format

Second-party audit

Auditing critical suppliers, third parties and strategic partners. For initial qualification or ongoing performance assessment under P7 requirements.

  • Qualification or requalification
  • Technical and regulatory assessment
  • A formal opinion and action plan
How we conduct audits

Four phases, one defensible outcome.

An audit planned and conducted under ISO 19011:2026, with formally defined criteria, scope and sampling throughout.

  1. Planning

    Formal definition of scope, criteria, objectives and sampling. Preliminary document review and alignment with senior management.

  2. Execution

    Opening meeting, interviews, document verification and sampling of objective evidence under the MDSAP Audit Approach. Full coverage of P1 to P7.

  3. Analysis and classification

    Categorisation of findings using the Grading System (Grade 1 to 5). Distinguishing documentary deviations from systemic failures affecting device safety.

  4. Report and CAPA

    A formal report with sampled evidence, categorised findings, proposed root causes and a CAPA action plan with deadlines, assigned owners and effectiveness indicators.

MDSAP Grading System

How we classify findings.

MDSAP categorises nonconformities into 5 levels. We distinguish documentary deviations from systemic failures.

Grade Severity Characteristic
G1 Minimal A minor deviation with no direct impact on device safety or performance. Straightforward remediation, often documentary.
G2 Moderate A documentary nonconformity that may develop into a systemic failure if left unaddressed. Requires formal root cause analysis.
G3 Significant A failure affecting the robustness of the QMS or a critical process. A mandatory action plan with an effectiveness indicator.
G4 Critical A systemic failure with a potential impact on device safety or performance. Requires immediate action.
G5 Major A direct risk to patient safety or the device's regulatory compliance. Immediate communication to the authorities.
What you receive

Audit deliverables.

A formal technical report

A complete document in the format expected by AOs: scope, criteria, sampled evidence, categorised findings (Grade 1-5) and proposed root cause analysis.

CAPA action plan

Structured CAPA with corrective and preventive actions, formal deadlines, named owners and objective post-implementation effectiveness indicators.

A prioritised action matrix

Ranking gaps by criticality, considering residual patient risk, regulatory impact and remediation complexity. Directing effort towards what matters.

Closing meeting

A closing meeting with senior management, presentation of findings, agreement on deadlines and owners, and definition of the implementation follow-up plan.

Auditing Recognised in 5 Countries

Our MDSAP internal auditing follows the official Audit Approach and ISO 19011:2026, with outputs in the format expected by the Auditing Organisations of the five regulatory authorities.

Brazilian Health Regulatory Agency (ANVISA). Regulates medical devices through RDCs, focusing on Good Manufacturing Practices and registration. Internal auditing across MDSAP's 7 processes is required to maintain the certificate and demonstrates continuous QMS self-assessment.

Principal RegulationRDC 665/2022
Quality SystemISO 13485
ClassificationClasses I, II, III and IV
RegistrationRDC 751/2022

Food and Drug Administration (FDA). QMSR replaced 21 CFR Part 820, aligned with ISO 13485:2016. Formal internal auditing is required by QMSR and ISO. Our methodology delivers a report with Grade 1-5 categorised findings, in the format expected by Auditing Organisations and FDA inspections.

Principal RegulationQMSR (21 CFR 820)
Quality SystemISO 13485
ClassificationClasses I, II and III
Approval510(k) / PMA / De Novo

Health Canada regulates through CMDR (SOR/98-282). A Medical Device Licence is mandatory for Classes II, III and IV. Internal auditing under MDSAP has been a Health Canada prerequisite since 2019. Our approach fully covers processes P1 to P7 with sampled objective evidence.

Principal RegulationCMDR (SOR/98-282)
Quality SystemISO 13485
ClassificationClasses I, II, III and IV
ApprovalMedical Device Licence

Ministry of Health, Labour and Welfare (MHLW) and PMDA. QMS under MHLW Ordinance No. 169. Shonin approval for high-risk devices. Our audit report meets the documentary structure required for pre-Shonin inspections and MDSAP certificate maintenance in Japan.

Principal RegulationMHLW Ordinance 169
Quality SystemISO 13485
ClassificationClasses I, II, III and IV
ApprovalShonin / Todokede

Therapeutic Goods Administration (TGA). Therapeutic Goods Act 1989 and ARTG (Australian Register). Mandatory conformity assessment. MDSAP internal auditing provides objective evidence for TGA during registration maintenance assessments and PRAC field actions.

Principal RegulationTG Act 1989
Quality SystemISO 13485
ClassificationClasses I, IIa, IIb, III and AIMD
ApprovalARTG Inclusion
FAQ

Frequently Asked Questions

Questions we receive before starting an MDSAP internal audit.

Is internal auditing an MDSAP requirement?

Yes. Process P3 (Measurement, Analysis and Improvement) requires a formal internal audit programme under ISO 13485 and ISO 19011. Without records of completed audits and addressed findings, the QMS is not ready to obtain or maintain MDSAP certification.

Do you audit all 7 processes in one engagement?

Yes. A complete internal audit fully covers all 7 processes (P1 to P7), with official tasks and linked items. For mature QMSs, we audit by critical process or cycle (six-monthly/annually), according to the company's governance strategy.

Can the report serve as objective evidence for the certification body?

Yes. The report follows the format expected by Auditing Organisations: scope, criteria, team, sampling, evidence, Grading System findings (Grade 1 to 5) and a CAPA plan. This is precisely the type of output the certification body seeks during the certification audit.

How long does a complete MDSAP internal audit take?

It depends on company size, portfolio complexity and QMS maturity. Generally, 3 to 8 days on site per audit cycle, with an additional 2 to 4 weeks for analysis, grading findings and producing the formal report.

Do you conduct second-party audits of critical suppliers?

Yes. Audits of suppliers and strategic partners for initial qualification or annual requalification under P7 requirements. Technical and regulatory assessment with a formal opinion and a supplier-specific action plan.

Why now?

The AO's next audit
will not wait for your QMS to be ready.

Companies that discover gaps during the certification audit pay a high price: Grade 4 and 5 findings can suspend the certificate, delay market access and lead to field actions. Structured internal auditing anticipates the problem while there is still time to resolve it.

5 countries simultaneous access
G1 → G5 official classification
ISO 19011 methodology applied

Or leave your details and we will get back to you:

We have received your details.

Our team will contact you shortly. Thank you!

Without internal auditing With HSC auditing
Findings discovered by the AO during certification Gaps addressed before the official audit
Risk of certificate suspension CAPA implemented and effectiveness validated
Grade 4 findings without a root cause Formal root cause analysis and a traceable action plan
Delayed access to the 5 markets Certification approved on the first attempt